|
Issue |
Title |
|
Vol 19, No 5 (2012) |
Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art |
Abstract
PDF
HTML
|
M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson |
|
Vol 17, No 4 (2010) |
BONUS 5: 5th Annual Bone and The Oncologist New Updates |
Abstract
PDF
|
N. Bouganim, E. Amir, M. Clemons |
|
Vol 23, No 5 (2016) |
Book review: Balanced Ethics Review: A Guide for Institutional Review Board Members |
Abstract
PDF
HTML
|
T. Christie |
|
Vol 23, No 1 (2016) |
Book review: Hypnotic Approaches in Cancer and Palliative Care |
Abstract
PDF
HTML
|
G. Giddings |
|
Vol 22, No 3 (2015) |
Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty |
Abstract
PDF
HTML
|
C.I. Falkson |
|
Vol 22, No 3 (2015) |
Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty |
Abstract
PDF
HTML
|
G. Giddings |
|
Vol 22, No 3 (2015) |
Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty |
Abstract
PDF
HTML
|
J. Ragaz, S. Shakeraneh |
|
Vol 13, No 5 (2006) |
Bortezomib in Multiple Myeloma and Lymphoma: A systematic review and clinical practice guideline |
Details
PDF
|
Christopher A Smith |
|
Vol 21, No 4 (2014) |
Bortezomib in multiple myeloma: systematic review and clinical considerations |
Abstract
PDF
HTML
|
T.C. Kouroukis, F.G. Baldassarre, A.E. Haynes, K. Imrie, D.E. Reece, M.C. Cheung |
|
Vol 21, No 6 (2014) |
BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients |
Abstract
PDF
HTML
|
W.Y. Fang, L. Ye, X.F. Zhang, L.Y. Shen, R.L. Han, Q. Wei, X.C. Fei, X. Chen, W.Q. Wang, S. Wang, G. Ning |
|
Vol 26, No 3 (2019) |
Brain cancer survival in Canada 1996–2008: effects of sociodemographic characteristics |
Abstract
PDF
HTML
|
E. V. Walker, J. Ross, Y. Yuan, T. R. Smith, F. G. Davis |
|
Vol 16, No 1 (2009) |
Brain Metastases from Unknown Primary or Primary Brain Tumor: A Diagnostic Dilemma |
Details
PDF
|
Sarah Campos, Philip Davey, Amanda Hird, Bryn Pressnail, Juan Bilbao, Richard Aviv, Sean Symons, Farhad Pirouzmand, Emily Sinclair, Shaelyn Culleton, Eric deSa, Philiz Goh, Edward Chow |
|
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist |
Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? |
Abstract
PDF
HTML
|
S. Morin-Ben Abdallah, A. Wong |
|
Vol 22, No 4 (2015) |
BRCA1/2 population screening: embracing the benefits |
Abstract
PDF
HTML
|
S.E. Plon |
|
Vol 18, No 1 (2011) |
Breaking new ground in a new year |
Details
PDF
HTML
|
M. McLean |
|
Vol 21, No 5 (2014) |
Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia |
Abstract
PDF
HTML
|
M. Corkum, R. Urquhart, G. Kephart, J.A. Hayden, G. Porter |
|
Vol 24, No 5 (2017) |
Breast cancer and dermatomyositis: a case study and literature review |
Abstract
PDF
HTML
|
E. Hendren, O. Vinik, H. Faragalla, R. Haq |
|
Vol 20, No 1 (2013) |
Breast cancer and the environment: what is left to learn? |
Details
PDF
HTML
|
S. Narod |
|
Vol 20, No 5 (2013) |
Breast cancer and the environment: why research and preventive action are needed |
Abstract
PDF
HTML
|
J.T. Brophy, M.M. Keith, R. Park, A. Watterson, M. Gilbertson, R. DeMatteo |
|
Vol 22, No 5 (2015) |
Breast cancer screening panels continue to confuse the facts and inject their own biases |
Abstract
PDF
HTML
|
D.B. Kopans |
|
Vol 20, No 2 (2013) |
Breast cancer survivorship and South Asian Women: understanding about the follow-up care plan and perspectives and preferences for information post treatment |
Abstract
PDF
HTML
|
S. Singh-Carlson, F. Wong, L. Martin, S.K.A. Nguyen |
|
Vol 24, No 3 (2017) |
Breast magnetic resonance imaging: are those who need it getting it? |
Abstract
PDF
HTML
|
S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop |
|
Vol 26, No 1 (2019) |
Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib |
Abstract
PDF
HTML
|
B. Melosky, P. Cheema, G. Liu |
|
2008: Presentations from the Integrating Wellness into Cancer Care Conference |
Bringing wellness back into health care: the role of social networks |
Abstract
PPT Presentation
|
Alex R. Jadad |
|
Vol 14, No 6 (2007) |
Broad funding for oxaliplatin in Ontario |
Details
PDF
|
Derek J Jonker |
|
Vol 24, No 3 (2017) |
Budget impact analysis of a breast rapid diagnostic unit |
Abstract
PDF
HTML
|
M. Elmi, H. Hussain, S. Nofech-Mozes, B. Curpen, A. Leahey, N. Look Hong |
|
Vol 25, No 6 (2018) |
Building an oncology community of practice to improve cancer care |
Abstract
PDF
HTML
|
W. Fingrut, L. A. Beck, D. Lo |
|
Vol 26, No 1 (2019) |
Building capacity in cancer knowledge translation through catalyst grants |
Abstract
PDF
HTML
|
M. A. O'Brien, E. Grunfeld |
|
Vol 23, No 6 (2016) |
Burden of illness for metastatic melanoma in Canada, 2011–2013 |
Abstract
PDF
HTML
|
D.S. Ernst, T. Petrella, A.M. Joshua, A. Hamou, M. Thabane, S. Vantyghem, F. Gwadry-Sridhar |
|
Vol 23, No 2 (2016) |
But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec |
Abstract
PDF
HTML
|
F. Labrèche, P. Duguay, A. Boucher, R. Arcand |
|
Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice |
Can less be more? Organ preservation strategies in the management of rectal cancer |
Abstract
PDF
HTML
|
F. Rouleau-Fournier, C. J. Brown |
|
Vol 21, No 2 (2014) |
Can oncologists predict survival for patients with progressive disease after standard chemotherapies? |
Abstract
PDF
HTML
|
T.K. Taniyama, K. Hashimoto, N. Kastumata, A. Hirakawa, K. Yonemori, M. Yunokawa, C. Shimizu, K. Tamura, M. Ando, Y. Fujiwara |
|
Vol 23, No 3 (2016) |
Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study |
Abstract
PDF
HTML
|
A. Arnaout, I. Kuchuk, N. Bouganim, G. Pond, S. Verma, R. Segal, S. Dent, S. Gertler, X. Song, F. Kanji, M. Clemons |
|
Vol 22, No 2 (2015) |
Canadian cancer screening disparities: a recent historical perspective |
Abstract
PDF
HTML
|
J. Kerner, J. Liu, K. Wang, S. Fung, C. Landry, G. Lockwood, L. Zitzelsberger, V. Mai |
|
Vol 18, No 5 (2011) |
Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens |
Abstract
PDF
HTML
|
A. J. Dawson, J. McGowan-Jordan, J. Chernos, J. Xu, J. Lavoie, J.-C. Wang, M. R. Steinraths, S. Shetty |
|
Vol 22, No 2 (2015) |
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis |
Abstract
PDF
HTML
|
J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan |
|
Vol 22, No 2 (2015) |
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment |
Abstract
PDF
HTML
|
J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan |
|
Vol 23, No 3 (2016) |
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer |
Abstract
PDF
HTML
|
B. Melosky, J. Agulnik, R. Albadine, S. Banerji, D.G. Bebb, D. Bethune, N. Blais, C. Butts, P. Cheema, P. Cheung, V. Cohen, J. Deschenes, D.N. Ionescu, R. Juergens, S. Kamel-Reid, S.A. Laurie, G. Liu, W. Morzycki, M.S. Tsao, Z. Xu, V. Hirsh |
|
Vol 26, No 1 (2019) |
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer |
Abstract
PDF
HTML
|
S. A. Laurie, S. Banerji, N. Blais, S. Brule, P. K. Cheema, P. Cheung, N. Daaboul, D. Hao, V. Hirsh, R. Juergens, J. Laskin, N. Leighl, R. MacRae, G. Nicholas, D. Roberge, J. Rothenstein, D. J. Stewart, M. S. Tsao |
|
Vol 25, No 5 (2018) |
Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia |
Abstract
PDF
HTML
Supplemental Material
|
C. Owen, A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, G. Fraser |
|
Vol 18, No 4 (2011) |
Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer |
Abstract
PDF
HTML
|
F. Aubin, S. Gill, R. Burkes, B. Colwell, S. Kamel–Reid, S. Koski, A. Pollett, B. Samson, M. Tehfe, R. Wong, S. Young, D. Soulieres |
|
Vol 18, No 3 (2011) |
Canadian initiatives for locally advanced breast cancer research and treatment: inaugural meeting of the Canadian Consortium for LABC |
Abstract
PDF
HTML
|
M. Brackstone, A. Robidoux, S. Chia, J. Mackey, R. Dent, J. F. Boileau, M. Clemons |
|
Vol 20, No 4 (2013) |
Canadian integrative oncology research priorities: results of a consensus-building process |
Abstract
PDF
HTML
|
L.C. Weeks, D. Seely, L.G. Balneaves, H.S. Boon, A. Leis, D. Oneschuk, S.M. Sagar, M.J. Verhoef |
|
Vol 24, No 4 (2017) |
Canadian Lung Cancer Conference 2017 |
Abstract
PDF
HTML
|
N. Chooback, B. Melosky, C. Ho |
|
Vol 25, No 3 (2018) |
Canadian Lung Cancer Conference 2018 |
Abstract
PDF
HTML
|
S. Lau, Y. Wang, C. Ho, B. Melosky |
|
Vol 26, No 4 (2019) |
Canadian Lung Cancer Conference 2019 |
Abstract
PDF
HTML
|
A. Pender, E. M. Dunne, S. K. Wong, C. Ho, B. Melosky |
|
Vol 25, No 5 (2018) |
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer |
Abstract
PDF
HTML
|
B. Melosky, P. Cheema, J. Agulnik, R. Albadine, D. G. Bebb, N. Blais, R. Burkes, C. Butts, P. B. Card, A.M Y. Chan, V. Hirsh, D. N. Ionescu, R Juergens, W. Morzycki, Z. Poonja, R. Sangha, M. Tehfe, M. S. Tao, M. Vincent, Z. Xu, G. Liu |
|
Vol 23, No 2 (2016) |
Canadian recommendations for the management of breakthrough cancer pain |
Abstract
PDF
HTML
|
P. Daeninck, B. Gagnon, R. Gallagher, J.D. Henderson, Y. Shir, C. Zimmermann, B. Lapointe |
|
Vol 14, No 3 (2007) |
Canadian Recommendations for the Treatment of Glioblastoma Multiforme |
Details
PDF
|
Warren Mason |
|
Vol 18, No 3 (2011) |
Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme |
Abstract
PDF
HTML
|
J. C. Easaw, W. P. Mason, J. Perry, N. Laperrière, D. D. Eisenstat, R. Del Maestro, K. Bélanger, D. Fulton, D. Macdonald |
|
Vol 14, No 5 (2007) |
Canadian Supportive Care Recommendations for the Management of Anemia in Patients with Cancer |
Details
PDF
|
Joseph Mikhael, Barbara Melosky, Christine Cripps, Daniel Rayson, Tom Kouroukis |
|
Vol 15, No 1 (2008) |
Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer |
Abstract
PDF
|
C. Tom Kouroukis, Joseph Mikhael, Sunil Verma, Stephen Chia, Christine Desbiens, Danny Robson, Christine Cripps |
|
Vol 20, No 1 (2013) |
Canadian trends in liver cancer: a brief clinical and epidemiologic overview |
Abstract
PDF
HTML
|
P. De, D. Dryer, M.C. Otterstatter, R. Semenciw |
|
Vol 15, No 6 (2008) |
CANCER AND THROMBOSIS: RECENT ADVANCES |
Abstract
PDF
|
Susan Solymoss |
|
Vol 21, No 3 (2014) |
Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management |
Abstract
PDF
HTML
|
E. Donnellan, B. Kevane, B.R. Healey Bird, F. Ni Ainle |
|
Vol 14, No 5 (2007) |
Cancer Antigen 125 in Ovarian Cancer Surveillance: A Decision Analysis Model |
Details
PDF
|
Laura Hopkins, Doug Coyle, Tien Le, Michael Fung Kee Fung, George Wells |
|
Vol 22, No 3 (2015) |
Cancer care burden: aiming at the Achilles heel |
Abstract
PDF
HTML
|
S. Ahmed, R.K. Shahid, K. Gesy |
|
Vol 23, No 6 (2016) |
Cancer care in South India: perspectives from visiting Canadian oncologists |
Abstract
PDF
HTML
|
S. Karim, J.C. Del Paggio, S.R. Berry, C.M. Booth |
|
Vol 19, No 1 (2012) |
Cancer control: life and death in an unequal world |
Abstract
PDF
HTML
|
S. B. Sutcliffe |
|
Vol 16, No 6 (2009) |
Cancer diagnostic assessment programs: standards for the organization of care in Ontario |
Abstract
PDF
|
T. Oliver, M. Brouwers, J. Crawford, P. Ellison, W. Evans, A. Gagliardi, J. Lacourciere, V. Mai, S. McNair, T. Minuk, l. Radeneck, C. Rand, J. Ross, D. Lo, J. Smylie, J. Srigley, H. Stern, M. Trudeau |
|
Vol 23, No 1 (2016) |
Cancer Evolution–Development: experience of hepatitis B virus–induced hepatocarcinogenesis |
Abstract
PDF
HTML
|
W.B. Liu, J.F. Wu, Y. Du, G.W. Cao |
|
Vol 23, No 4 (2016) |
Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba |
Abstract
PDF
HTML
|
K.M. Decker, E.V. Kliewer, A.A. Demers, K. Fradette, N. Biswanger, G. Musto, B. Elias, D. Turner |
|
2008: Presentations from the Integrating Wellness into Cancer Care Conference |
CANCER IS A WORD NOT A SENTENCE |
Abstract
PPT Presentation
|
Robert Buckman |
|
Vol 20, No 2 (2013) |
Cancer Narratives: Words Beyond Disease A Call for Submissions |
Details
PDF
HTML
|
D. Rayson |
|
Vol 15, No 3 (2008) |
Cancer Nutrition and Rehabilitation – Its Time has Come! |
Abstract
PDF
|
Martin R. Chasen |
|
Vol 17, No 6 (2010) |
Cancer nutrition rehabilitation program: the role of social work |
Abstract
PDF
|
D. Townsend, C. Accurso–Massana, C. Lechman, S. Duder, M. Chasen |
|
Vol 23, No 6 (2016) |
Cancer referral and treatment activity 2010–2015: a population-based study from Vancouver Island |
Abstract
PDF
HTML
|
P. Savage, C. Holloway, G. Lindsay, K. Shubrook, C. Jones, M. Fung, K. Schaff, H. Anderson, K. Nystedt, J. Rauw |
|
Vol 18, No 6 (2011) |
Cancer risk: are we well behaved? |
Abstract
PDF
HTML
|
A. G. Cramp, L. Fitzgeorge, H. Prapavessis |
|
Vol 12, No 4 (2005) |
Cancer Stem Cells Revisited |
Details
PDF
|
Richard J Ablin, Brian L. Pipes |
|
Vol 14, No 3 (2007) |
Cancer Symptom Control Trials: How May We Advance This Field? |
Details
PDF
|
Neil MacDonald |
|
Aromatase Inhibitor Supplement, 2007 |
Cancer Therapy Disparity— Unequal Access to Breast Cancer Therapeutics and Drug Funding in Canada |
Details
PDF
|
Sunil Verma, Sandeep Sehdev, Anil Abraham Joy |
|
Going Beyond Efficacy |
Cancer Treatment Related Bone Loss |
Abstract
PDF
|
Aliya Khan, Nazir Khan |
|
Going Beyond Efficacy |
Cancer-Associated Thrombosis: Prevention and Treatment |
Details
PDF
|
Agnes Lee, Kelsey Brose |
|
Vol 23 (2016): Use of Cannabinoids in Cancer Care |
Cannabis and cancer: towards a new understanding |
Abstract
PDF
HTML
|
M.A. Ware |
|
Vol 26, No 4 (2019) |
Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada |
Abstract
PDF
HTML
|
P. Hawley, M. Gobbo |
|
Vol 18, No 2 (2011) |
Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost–consequence analysis |
Abstract
PDF
HTML
|
A. M. Horgan, J. J. Knox, G. Liu, C. Sahi, P. A. Bradbury, N B. Leighl |
|
Vol 17, No 1 (2010) |
Capecitabine-induced cardiotoxicity: case report and review of the literature |
Abstract
PDF
|
C. Ang, M. Kornbluth, M.P. Thirlwell, R.D. Rajan |
|
Vol 24, No 3 (2017) |
Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy |
Abstract
PDF
HTML
|
N. Chooback, Y. Shen, M. Jones, K. Kasaian, M. Martin, T. Ng, T. Thompson, M. Marra, J. Laskin, C. Ho |
|
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective |
Cardiac and cognitive effects of androgen deprivation therapy: are they real? |
Abstract
PDF
|
S. M.H. Alibhai, H. Z. Mohamedali |
|
Vol 15, No 1 (2008) |
Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group |
Abstract
PDF
|
John Mackey, Mark Clemons, Sunil Verma, Diego Delgado, Susan Dent, Alexander Paterson, Louise Provencher, Michael Sawyer, Marc Andre Cote |
|
Vol 18, No 5 (2011) |
Caring for survivors of breast cancer: perspective of the primary care physician |
Abstract
PDF
HTML
|
S. L. Smith, E. S. Wai, C. Alexander, S. Singh-Carlson |
|
Vol 20, No 2 (2013) |
Case report of very late gastric cancer recurrence |
Abstract
PDF
HTML
|
P. Blanchette, J.H. Lipton, D. Barth, H. Mackay |
|
Vol 19, No 3 (2012) |
Casting stones and casting aspersions: let’s not lose sight of the main issues in the euthanasia debate |
Abstract
PDF
HTML
|
Jose Pereira |
|
Vol 19, No 3 (2012) |
Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy |
Abstract
PDF
HTML
|
G. Lee, M. Clemons, J. Cho, G.J. Czarnota, R. Dinniwell |
|
Vol 22, No 5 (2015) |
Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer |
Abstract
PDF
HTML
|
A.G. Robinson, K. Young, K. Balchin, A. Ashworth, T. Owen |
|
Vol 17, No 4 (2010) |
Cetuximab in locally advanced head-and-neck cancer: defining the population |
Abstract
PDF
|
C. Ho |
|
Vol 15, No 4 (2008) |
Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and Psoriasis |
Details
PDF
|
Bart Neyns, Vanessa Meert, Frederik Vandenbroucke |
|
Vol 24, No 2 (2017) |
Challenges and insights in implementing coordinated care between oncology and primary care providers: a Canadian perspective |
Abstract
PDF
HTML
|
J.R. Tomasone, M. Vukmirovic, M.C. Brouwers, E. Grunfeld, R. Urquhart, M.A. O’Brien, M. Walker, F. Webster, M. Fitch |
|
Vol 21, No 2 (2014) |
Challenges and outcomes of a randomized study of early nutrition support during autologous stem-cell transplantation |
Abstract
PDF
HTML
|
N. Kiss, J. Seymour, M. Prince, G. Dutu |
|
Vol 19, No 1 (2012) |
Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care |
Abstract
PDF
HTML
|
G. P. Browman |
|
Vol 17, No 3 (2010) |
Challenging obesity relating to Barrett esophagitis |
Abstract
PDF
|
L. Z.G. Touyz |
|
Vol 25, No 5 (2018) |
Changes in preoperative endoscopic and percutaneous bile drainage in patients with periampullary cancer undergoing pancreaticoduodenectomy in Ontario: effect on clinical practice of a randomized trial |
Abstract
PDF
HTML
|
D. J. Kagedan, J. D. Mosko, M. E. Dixon, P. J. Karanicolas, A. C Wei, N. Goyert, Q. Li, N. Mittmann, N. G. Coburn |
|
Vol 22, No 6 (2015) |
Characteristics affecting survival after locally advanced colorectal cancer in Quebec |
Abstract
PDF
HTML
|
L. Perron, J.M. Daigle, N. Vandal, M.H. Guertin, J. Brisson |
|
Vol 24, No 2 (2017) |
Characteristics predicting outcomes of allogeneic stem-cell transplantation in relapsed acute myelogenous leukemia |
Abstract
PDF
HTML
|
J. Frazer, S. Couban, S. Doucette, S. Shivakumar |
|
Vol 18, No 1 (2011) |
Characterization of published errors in high-impact oncology journals |
Abstract
PDF
HTML
|
A. Molckovsky, M. M. Vickers, P. A. Tang |
|
Vol 19, No 2 (2012) |
Characterizing distress, the 6th vital sign, in an oncology pain clinic |
Abstract
PDF
HTML
|
A. Waller, S.L. Groff, N. Hagen, B.D. Bultz, L.E. Carlson |
|
Vol 22, No 3 (2015) |
Charms of a silver watch |
Abstract
PDF
HTML
|
S.A. Bawany |
|
Vol 24, No 1 (2017) |
Chemonaïveté in inoperable malignant bowel obstruction |
Abstract
PDF
HTML
|
S. Boutayeb, I. El Ghissassi, H. Mrabti, H. Errihani |
|
Going Beyond Efficacy |
Chemotherapy and cancer related nausea and vomiting |
Abstract
PDF
|
David Warr |
|
Vol 20, No 5 (2013) |
Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline |
Abstract
PDF
HTML
|
A.A. Gupta, X. Yao, S. Verma, H. Mackay, L. Hopkins, on behalf of the Sarcoma Disease Site Group and he Gynecology Cancer Disease Site Group |
|
201 - 300 of 1685 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |